Gary Knudson, MD
Orthopaedic Surgery · Waterloo, IANPI 1700813441
Payments from drug & device makers
Across 65 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$370
- Pacira Therapeutics, Inc.$230
- Stryker$187
- Bioventus LLC$124
- Ferring Pharmaceuticals Inc.$62
- Pfizer$51
- plus $403 from 17 others
What the payments were for
- Food & beverage$1,427100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $370 |
| Pacira Therapeutics, Inc. | 11 | $230 |
| Stryker | 7 | $187 |
| Bioventus LLC | 6 | $124 |
| Ferring Pharmaceuticals Inc. | 4 | $62 |
| Pfizer | 4 | $51 |
| Axogen | 1 | $43 |
| Smith+Nephew | 1 | $35 |
| Encore Medical, LP | 2 | $35 |
| Vertex | 2 | $32 |
| Zimmer Biomet | 2 | $28 |
| Radius Health, Inc. | 1 | $27 |
| AbbVie | 2 | $26 |
| SPR Therapeutics, Inc | 1 | $26 |
| Sonex Health, Inc. | 1 | $20 |
| Heraeus Medical, LLC. | 1 | $20 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Amgen | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Treace Medical Concepts, Inc. | 1 | $16 |
| Solventum Corporation | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| DJO, LLC | 1 | $12 |
How this compares
$1,427 in reported general payments places this provider in the 40th percentile of 219 orthopaedic surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 86 | $95 |
| Clindamycin Hcl | 24 | $17 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Waterloo
- Jay GintherWaterloo$15K
- Mark GorscheWaterloo$10K
- John CallaghanIowa City$23.3M
- Cesar de Cesar NettoIowa City$905K
- Brian AdamsIowa City$868K
- Lynn NelsonBelmond$285K
- Robert WestermannIowa City$216K
- Jacob ElkinsIowa City$188K
- Brendan PattersonIowa City$166K
- Joseph BuckwalterIowa City$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.